Annales d'endocrinologie
Letter to the editor: Cost utility of second-line acromegaly treatment in France (Raverot et al., 2025).
Dédé Sika Kossi
Published: 202610.1016/j.ando.2025.102480
No abstract available for this study.
Dédé Sika Kossi
No abstract available for this study.